|
Delayed
Bombay S.E.
02:42:55 2026-10-29 EDT
|
5-day change | 1st Jan Change | ||
| 25.00 INR | 0.00% |
|
+6.75% | -37.50% |
| Market Cap | 250M 2.62M 2.36M 2.18M 1.97M 3.68M 3.73M 26.03M 10.37M 131M 9.85M 9.64M 415M | P/E 2025 |
7.01x | P/E 2026 | -7.97x |
|---|---|---|---|---|---|
| Enterprise Value | 862M 9.05M 8.12M 7.5M 6.8M 12.7M 12.85M 89.73M 35.74M 451M 33.95M 33.23M 1.43B | EV / Sales 2025 |
0.52x | EV / Sales 2026 | 1.02x |
| Free-Float |
38.75% | Yield 2025 * |
-
| Yield 2026 | - |
| 1 week | +6.75% | ||
| Current month | +2.21% | ||
| 1 month | +0.36% | ||
| 3 months | +1.01% | ||
| 6 months | +1.79% | ||
| Current year | -37.50% |
| 1 week | 21 | 25.6 | |
| 1 month | 21 | 29 | |
| Current year | 20.61 | 42.9 | |
| 1 year | 20.61 | 43 | |
| 3 years | 20.61 | 122 | |
| 5 years | 20.61 | 122 | |
| 10 years | 8 | 132.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
Dilipkumar Shah
CEO | Chief Executive Officer | - | - |
| Director of Finance/CFO | - | 2019-08-11 | |
Puneeta Sharma
CMP | Compliance Officer | - | 2019-05-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Tanvi Shah
CHM | Chairman | - | 2019-04-07 |
Ankur Dave
BRD | Director/Board Member | 53 | 2019-03-22 |
| Director/Board Member | - | 2022-11-13 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| 0.00% | +6.75% | -26.12% | -72.51% | 2.62M | ||
| +0.50% | +1.38% | +57.09% | +129.96% | 1,148B | ||
| +0.86% | +5.14% | +45.00% | +86.15% | 652B | ||
| -0.14% | +0.42% | +25.69% | +105.85% | 505B | ||
| +0.55% | +2.07% | +53.69% | +65.85% | 384B | ||
| -0.63% | -5.97% | +61.93% | +37.06% | 348B | ||
| +2.03% | +1.72% | +33.10% | +54.91% | 294B | ||
| +1.19% | -0.72% | +2.60% | +26.11% | 264B | ||
| +0.87% | +3.08% | +54.69% | +72.74% | 244B | ||
| +0.08% | +3.67% | +35.05% | +107.78% | 197B | ||
| Average | +0.52% | +1.80% | +34.27% | +61.39% | 403.72B | |
| Weighted average by Cap. | +0.54% | +1.50% | +44.77% | +88.97% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 963M 10.11M 9.07M 8.39M 7.59M 14.19M 14.36M 100M 39.93M 504M 37.93M 37.13M 1.6B | 846M 8.88M 7.97M 7.37M 6.67M 12.47M 12.62M 88.11M 35.09M 443M 33.34M 32.63M 1.41B |
| Net income | 50.57M 531K 476K 440K 399K 745K 754K 5.27M 2.1M 26.46M 1.99M 1.95M 84.01M | -32.01M -336K -302K -279K -252K -472K -477K -3.33M -1.33M -16.75M -1.26M -1.23M -53.17M |
| Net Debt | 142M 1.49M 1.34M 1.24M 1.12M 2.1M 2.12M 14.82M 5.9M 74.48M 5.61M 5.49M 236M | 612M 6.42M 5.76M 5.33M 4.82M 9.01M 9.12M 63.69M 25.37M 320M 24.1M 23.59M 1.02B |
Employees
41
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-29 | ₹25.00 | 0.00% | 68 |
| 26-10-28 | ₹25.00 | +1.67% | 666 |
| 26-10-27 | ₹24.59 | +2.46% | 1,427 |
| 26-10-26 | ₹24.00 | +6.19% | 1,057 |
| 26-10-23 | ₹22.60 | -3.50% | 390 |
- Stock Market
- Stocks
- ICLF Stock
Select your edition
All financial news and data tailored to specific country editions
















